News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
284,287 Results
Type
Article (11373)
Company Profile (8)
Press Release (272906)
Multimedia
Podcasts (26)
Webinars (6)
Section
Business (78584)
Career Advice (267)
Deals (20319)
Drug Delivery (50)
Drug Development (35979)
Employer Resources (23)
FDA (7745)
Job Trends (6421)
News (147888)
Policy (18366)
Tag
Academia (506)
Accelerated approval (21)
Adcomms (8)
Allergies (69)
Alliances (16541)
ALS (58)
Alzheimer's disease (689)
Antibody-drug conjugate (ADC) (106)
Approvals (7958)
Artificial intelligence (143)
Autoimmune disease (55)
Automation (14)
Bankruptcy (209)
Best Places to Work (5577)
BIOSECURE Act (10)
Biosimilars (103)
Biotechnology (10)
Bladder cancer (85)
Brain cancer (29)
Breast cancer (318)
Cancer (2235)
Cardiovascular disease (149)
Career advice (245)
Career pathing (2)
CAR-T (97)
CDC (18)
Cell therapy (283)
Cervical cancer (17)
Clinical research (32287)
Collaboration (587)
Compensation (451)
Complete response letters (40)
COVID-19 (978)
CRISPR (30)
C-suite (296)
Cystic fibrosis (64)
Data (3310)
Denatured (2)
Depression (79)
Diabetes (237)
Diagnostics (2999)
Digital health (14)
Diversity (4)
Diversity, equity & inclusion (10)
Drug discovery (60)
Drug pricing (117)
Drug shortages (18)
Duchenne muscular dystrophy (122)
Earnings (43793)
Editorial (29)
Employer branding (1)
Employer resources (21)
Events (39441)
Executive appointments (370)
FDA (9568)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (5)
Frontotemporal dementia (9)
Funding (414)
Gene editing (68)
Generative AI (8)
Gene therapy (228)
GLP-1 (343)
Government (2502)
Guidances (328)
Healthcare (7080)
HIV (31)
Huntington's disease (15)
IgA nephropathy (53)
Immunology and inflammation (86)
Immuno-oncology (21)
Indications (57)
Infectious disease (1083)
Inflammatory bowel disease (79)
Inflation Reduction Act (5)
Influenza (64)
Intellectual property (179)
Interviews (31)
IPO (11732)
IRA (32)
Job creations (1108)
Job search strategy (218)
JPM (15)
Kidney cancer (12)
Labor market (14)
Layoffs (168)
Leadership (4)
Legal (5406)
Liver cancer (33)
Longevity (3)
Lung cancer (298)
Lymphoma (202)
Machine learning (13)
Management (5)
Manufacturing (313)
MASH (97)
Medical device (5989)
Medtech (6007)
Mergers & acquisitions (9399)
Metabolic disorders (594)
Multiple sclerosis (91)
NASH (8)
Neurodegenerative disease (109)
Neuropsychiatric disorders (37)
Neuroscience (1186)
NextGen: Class of 2026 (2043)
Non-profit (987)
Now hiring (3)
Obesity (258)
Opinion (93)
Ovarian cancer (96)
Pain (101)
Pancreatic cancer (110)
Parkinson's disease (82)
Partnered (8)
Patents (373)
Patient recruitment (184)
Peanut (21)
People (19931)
Pharmaceutical (4)
Pharmacy benefit managers (27)
Phase 1 (9045)
Phase 2 (13898)
Phase 3 (11921)
Pipeline (3197)
Policy (194)
Postmarket research (1023)
Preclinical (3339)
Press Release (24)
Prostate cancer (126)
Psychedelics (14)
Radiopharmaceuticals (115)
Rare diseases (385)
Real estate (1487)
Recruiting (7)
Regulatory (12975)
Reports (9)
Research institute (461)
Resumes & cover letters (19)
Rett syndrome (22)
RNA editing (2)
RSV (35)
Schizophrenia (72)
Series A (37)
Series B (31)
Sickle cell disease (37)
Special edition (7)
Spinal muscular atrophy (71)
Sponsored (4)
Startups (723)
State (1)
Stomach cancer (3)
Supply chain (54)
Tariffs (57)
The Weekly (23)
Vaccines (367)
Venture capital (17)
Weight loss (162)
Women's health (22)
Date
Last 7 days (268)
Last 30 days (950)
Last 365 days (15023)
2026 (1319)
2025 (15201)
2024 (17063)
2023 (19611)
2022 (21386)
2021 (24101)
2020 (23693)
2019 (17838)
2018 (14070)
2017 (14887)
2016 (12447)
2015 (15738)
2014 (10928)
2013 (8073)
2012 (8868)
2011 (9397)
2010 (8296)
Location
Africa (204)
Alabama (52)
Alaska (2)
Arizona (97)
Arkansas (4)
Asia (15856)
Australia (2407)
California (6075)
Canada (1605)
China (400)
Colorado (250)
Connecticut (254)
Delaware (129)
Europe (33180)
Florida (862)
Georgia (194)
Hawaii (1)
Idaho (21)
Illinois (339)
India (26)
Indiana (336)
Iowa (9)
Japan (161)
Kansas (68)
Kentucky (7)
Louisiana (9)
Maine (43)
Maryland (714)
Massachusetts (3727)
Michigan (87)
Minnesota (250)
Mississippi (2)
Missouri (37)
Montana (12)
Nebraska (6)
Nevada (53)
New Hampshire (43)
New Jersey (1763)
New Mexico (2)
New York (1758)
North Carolina (541)
North Dakota (2)
Northern California (3010)
Ohio (91)
Oklahoma (6)
Oregon (2)
Pennsylvania (1189)
Puerto Rico (15)
Rhode Island (7)
South America (367)
South Carolina (21)
Southern California (2416)
Tennessee (55)
Texas (925)
United States (20354)
Utah (194)
Virginia (115)
Washington D.C. (46)
Washington State (487)
West Virginia (1)
Wisconsin (32)
Wyoming (2)
284,287 Results for "federal trade commission".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Legal
Former Emergent CEO Hit With Insider Trading Lawsuit
Robert Kramer, former CEO of Emergent BioSolutions, allegedly earned more than $10.1 million by executing trades with information related to the company’s manufacturing operations that had yet to be made public.
January 16, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq
January 26, 2026
·
5 min read
Drug pricing
Trump To Target Trading Partners With Drug Pricing Probe: Report
While the threat of tariffs dies down for the pharma industry, President Donald Trump is reportedly weighing a new investigation that could result in import taxes against U.S. trading partners that don’t pay enough for drugs.
October 22, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
AstraZeneca begins trading on the New York Stock Exchange
February 2, 2026
·
2 min read
China
Amid Trade Tensions, Commission Warns China is ‘Dangerously Close’ to Overtaking US Biotech
The National Security Commission on Emerging Biotechnology recommends at least a $15 billion investment into biotech over the next five years.
April 9, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol “PLYX”
February 2, 2026
·
5 min read
Press Releases
Avacta Announces Year-end Trading Update
January 20, 2026
·
11 min read
Press Releases
NervGen Pharma Begins Trading on Nasdaq Today
January 8, 2026
·
6 min read
Press Releases
Biomind Labs Announces Revocation of Cease Trade Order
November 26, 2025
·
7 min read
Press Releases
Definium Therapeutics Common Shares to Trade under New Nasdaq Ticker Symbol “DFTX” Effective January 15, 2026
January 13, 2026
·
3 min read
1 of 28,429
Next
